EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Immunosenescence and Inflammaging in COVID-19

Faezeh Asghari, Amir Asghary, Naime Majidi Zolbanin, Fatemeh Faraji iD, Reza Jafari

Viral Immunology · 2023

DOI: 10.1089/vim.2023.0045 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viral Immunology, 2023. Verfasst von Faezeh Asghari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Medicine, Tarbiat Modares University, Tehran, Iran. Hauptthemen laut MEDLINE: Immunosenescence, COVID-19. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 187 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite knowledge gaps in understanding the full spectrum of the hyperinflammatory phase caused by SARS-CoV-2, according to the World Health Organization (WHO), COVID-19 is still the leading cause of death worldwide. Susceptible people to severe COVID-19 are those with underlying medical conditions or those with dysregulated and senescence-associated immune responses. As the immune system undergoes aging in the elderly, such drastic changes predispose them to various diseases and affect their responsiveness to infections, as seen in COVID-19. At-risk groups experience poor prognosis in terms of disease recovery. Changes in the quantity and quality of immune cell function have been described in numerous literature sites. Impaired immune cell function along with age-related metabolic changes can lead to features such as hyperinflammatory response, immunosenescence, and inflammaging in COVID-19. Inflammaging is related to the increased activity of the most inflammatory factors and is the main cause of age-related diseases and tissue failure in the elderly. Since hyperinflammation is a common feature of most severe cases of COVID-19, this pathway, which is not fully understood, leads to immunosenescence and inflammaging in some individuals, especially in the elderly and those with comorbidities. In this review, we shed some light on the age-related abnormalities of innate and adaptive immune cells and how hyperinflammatory immune responses contribute to the inflammaging process, leading to clinical deterioration. Further, we provide insights into immunomodulation-based therapeutic approaches, which are potentially important considerations in vaccine design for elderly populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunosenescenceCOVID-19HumansAgedInflammationSARS-CoV-2Aging

Stichwörter der Autor:innen

COVID-19hyperinflammatory phaseimmunosenescenceinflammaging

Autor:innen und Institutionen

  • Department of Immunology, School of Medicine, Tarbiat Modares University, Tehran, Iran.
  • Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
  • Experimental and Applied Pharmaceutical Research Center, Urmia University of Medical Sciences, Urmia, Iran.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran.
  • Antimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran.
  • Cellular and Molecular Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran.

ORCID-Profile: Fatemeh Faraji

Zitieren

APA

Asghari, F., Asghary, A., Majidi Zolbanin, N., Faraji, F., & Jafari, R. (2023). Immunosenescence and Inflammaging in COVID-19. Viral Immunology. https://doi.org/10.1089/vim.2023.0045

Vancouver

Asghari F, Asghary A, Majidi Zolbanin N, Faraji F, Jafari R. Immunosenescence and Inflammaging in COVID-19. Viral Immunology. 2023. doi:10.1089/vim.2023.0045

BibTeX
@article{Asghari2023,
  author = {Asghari, Faezeh and Asghary, Amir and Majidi Zolbanin, Naime and Faraji, Fatemeh and Jafari, Reza},
  title = {Immunosenescence and Inflammaging in COVID-19},
  journal = {Viral Immunology},
  year = {2023},
  doi = {10.1089/vim.2023.0045}
}
Kostenlos starten →